Menu Menu

DNLI    Denali Therapeutics Inc    1714899    
Income Statement
Net Income dnli-20241231 -422,773,000

Balance Sheet
Current Assets 864,436,000
Assets 1,374,180,000
Current Liabilities 102,208,000
Liabilities 144,496,000
Equity 1,229,684,000
Shares Out 143,165,000

Cash Flow Statement
Operating Cash Flow -347,694,000
Investing Cash Flow -88,756,000

Market Analysis
Market Cap 4,363,675,230
Price 14.68
BVPS 8.59
PB 1.72
EPS -2.85
PS 0.76
FCF -436,450,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/27 -2.57
Apr May Jun
5/07 -0.68
Jul Aug Sep
8/01 -0.59
Oct Nov Dec
11/05

Find a discrepancy? The most accurate way to find company fundamental data is to view DNLI documents filed with the SEC.


DNLI Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas